Publicaciones en colaboración con investigadores/as de Institute of Oncology Ljubljana (1)

2022

  1. Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

    Cancer Discovery, Vol. 12, Núm. 5, pp. 1248-1265